The American Journal of Medicine
Volume 122, Issue 3 , Pages 239-241 , March 2009

Impervious

  • Paul F. Haggerty, MD

      Affiliations

    • Department of Internal Medicine, Wright-Patterson Medical Center, Wright-Patterson Air Force Base, OH
    • Corresponding Author InformationRequests for reprints should be addressed to Paul F. Haggerty, MD, 4881 Sugar Maple Drive, 88th MDOS/SGOMI, Wright-Patterson Air Force Base, OH, 45433
    • ,
  • Eric S. Halsey, MD

      Affiliations

    • Department of Infectious Diseases, Wright-Patterson Medical Center, Wright-Patterson Air Force Base, OH

References 

  1. Arens MQ, Swierkosz EM. Susceptibility Test Methods: Viruses. In:  Murray PR,  Baron EJ,  Jorgensen JH,  Landry ML,  Pfaller MA editor. Manual of Clinical Microbiology. 9th Ed.. Washington, DC: ASM Press; 2007;p. 1705–1718
  2. Toro JR, Sanchez S, Turiansky G, Blauvelt A. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox. Dermatol Clin. 2003;21:301–309
  3. Norris SA, Kessler HA, Fife KH. Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS. J Infect Dis. 1988;157:209–210
  4. Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003;26:29–37
  5. Kriesel JD, Spruance SL, Prichard M, et al. Recurrent antiviral-resistant genital herpes in an immunocompetent patient. J Infect Dis. 2005;192:156–161
  6. Bernstein DI, Spruance SL, Arora SS, et al. Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study. Clin Infect Dis. 2005;41:808–814
  7. Lalezari J, Schacker T, Feinberg J. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS. J Infect Dis. 1997;176:892–898
  8. Duncan RA, von Reyn CF, Alliegro GM, et al. Idiopathic CD4+ T-lymphocytopenia—four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med. 1993;328:393–398

 Parwathi “Uma” Paniker, MD, Section Editor

 The views expressed in this article are those of the authors and do not reflect the official policy of the Department of the Air Force, the Department of Defense, or the US Government.

 Funding: There are no financial disclosures to report for Dr. Haggerty or Dr. Halsey, and there are no funding sources to report.

 Conflict of Interest: Neither Dr. Haggerty nor Dr. Halsey have any potential conflicts of interest to report.

 Authorship: Dr. Haggerty and Dr. Halsey had full access to all of the data and take full responsibility for the integrity of the data, the accuracy of the data analysis, and the writing of this manuscript.

PII: S0002-9343(08)01154-6

doi: 10.1016/j.amjmed.2008.11.007

The American Journal of Medicine
Volume 122, Issue 3 , Pages 239-241 , March 2009

Article Tools

* Image Usage & Resolution